BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 702178)

  • 1. Inhibition of dopamine-sensitive adenylate cyclase in rat striatum by neuroleptic drugs administered in vivo.
    Nakahara T; Uchimura H; Saito M; Hirano M; Kim JS; Ito M
    J Neurochem; 1978 Nov; 31(5):1335-7. PubMed ID: 702178
    [No Abstract]   [Full Text] [Related]  

  • 2. Factors affecting solubilized dopamine-sensitive adenylate cyclase.
    Marshall AM; Ramwani J; Mishra RK
    Biochem Pharmacol; 1983 Apr; 32(7):1237-41. PubMed ID: 6847713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specificity of the dopamine sensitive adenylate cyclase for antipsychotic antagonists.
    Roufogalis BD; Thornton M; Wade DN
    Life Sci; 1976 Sep; 19(6):927-34. PubMed ID: 966971
    [No Abstract]   [Full Text] [Related]  

  • 4. Striatal adenylate cyclase activity following reserpine and chronic chlorpromazine administration in rats.
    Rotrosen J; Friedman E; Gershon S
    Life Sci; 1975 Aug; 17(4):563-8. PubMed ID: 171534
    [No Abstract]   [Full Text] [Related]  

  • 5. Characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the frontal cerebral cortex of the rat. Comparative effects of neuroleptics on frontal cortex and striatal dopamine sensitive adenylate cyclases.
    Bockaert J; Tassin JP; Thierry AM; Glowinski J; Premont J
    Brain Res; 1977 Feb; 122(1):71-86. PubMed ID: 837225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different dopamine stimulation of adenylate cyclase in striatum and mesolimbic area of rats treated with chronic chlorpromazine.
    Kaneno S; Watanabe S; Toru M; Shimazono Y
    Brain Res; 1978 Aug; 152(2):396-400. PubMed ID: 679034
    [No Abstract]   [Full Text] [Related]  

  • 7. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
    Hungen KV; Roberts S; Hill DF
    Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haloperidol increases and apomorphine decreases striatal dopamine metabolism after destruction of striatal dopamine-sensitive adenylate cyclase by kainic acid.
    Di Chiara G; Porceddu ML; Spano PF; Gessa GL
    Brain Res; 1977 Jul; 130(2):374-82. PubMed ID: 884534
    [No Abstract]   [Full Text] [Related]  

  • 9. Stimulation of a dopamine-sensitive adenylate cyclase in homogenates of rat striatum by a metabolite of piribedil (ET 495).
    Miller RJ; Iversen LL
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(2):213-6. PubMed ID: 4369214
    [No Abstract]   [Full Text] [Related]  

  • 10. Neurohumoral regulation of adenylate cyclase activity in rat striatum.
    Walker JB; Walker JP
    Brain Res; 1973 May; 54():386-90. PubMed ID: 4145382
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased sensitivity of adenylate cyclase activity in the striatum of the rat to calmodulin and GppNHp after chronic treatment with haloperidol.
    Treisman GJ; Muirhead N; Gnegy ME
    Neuropharmacology; 1986 Jun; 25(6):587-95. PubMed ID: 3092124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcellular localization of dopamine-sensitive adenylate cyclase in rat brain striatum.
    Laduron P; Verwimp M; Janssen PF; Leysen J
    Life Sci; 1976 Feb; 18(4):433-9. PubMed ID: 130527
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of some derivatives of 2-aminotetralin on dopamine-sensitive adenylate cyclase and on the binding of (3H)haloperidol to neuroleptic receptors in the rat striatum.
    Cannon JG; Costall B; Laduron PM; Leysen JE; Naylor RJ
    Biochem Pharmacol; 1978 May; 27(10):1417-20. PubMed ID: 567987
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative study of the dopamine-sensitive adenylate cyclase in the striatum and hypothalamus of rat brain.
    Roufogalis BD; Thornton M; Wade DN
    J Pharm Pharmacol; 1979 Jan; 31(1):33-8. PubMed ID: 32363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic drugs and dopamine-stimulated adenylate cyclase prepared from corpus striatum of rat brain.
    Karobath M; Leitich H
    Proc Natl Acad Sci U S A; 1974 Jul; 71(7):2915-8. PubMed ID: 4527668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a connection between high affinity 3H-spiperone binding sites and DA-sensitive adenylate cyclase in corpus striatum?
    Marchais D; Bockaert J
    Biochem Pharmacol; 1980 May; 29(10):1331-6. PubMed ID: 7053066
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of the inhibitory effects of neuroleptic drugs on adenylate cyclase in rat tissues stimulated by dopamine, noradrenaline and glucagon.
    Miller RJ
    Biochem Pharmacol; 1976 Mar; 25(5):537-41. PubMed ID: 942490
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of morphine sulfate on adenylate cyclase and phosphodiesterase activities in rat corpus striatum.
    Puri SK; Cochin J; Volicer L
    Life Sci; 1975 Mar; 16(5):759-67. PubMed ID: 164598
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of penfluridol of dopamine-sensitive adenylate cyclase in corpus striatum and substantia nigra of rats.
    Seeber U; Kuschinsky K
    Experientia; 1976 Dec; 32(12):1558-9. PubMed ID: 191279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of dopamine sensitive adenylate cyclase from rat brain striatal homogenates by ascorbic acid.
    Thomas TN; Zemp JW
    J Neurochem; 1977 Mar; 28(3):663-5. PubMed ID: 853306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.